| Utilization of dried blood spots within drug discovery: modification of a standard DiLab(R) AccuSampler(R) to facilitate automatic dried blood spot sampling. | |
| | |
MedLine Citation:
|
PMID: 21355022 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The use of dried blood spots (DBS) in preclinical studies has seen an enormous increase over the past two years. Despite its positive impact on the 3Rs (reduce, replace and refine), its uptake in exploratory drug discovery has been limited due mainly to protracted method development time in bioanalysis but also the need for small volumes (<20 μL) to be sampled manually. Automatic blood sampling technology such as the DiLab(®) AccuSampler(®) is widely used in drug discovery to facilitate exploratory rodent-based pharmacokinetic and pharmacokinetic/pharmacodynamic studies with minimal animal handling. Propranolol was orally administered to a Han-Wistar rat attached to either a standard DiLab(®) AccuSampler(®) or a retrofitted unit designed to directly collect the DBS samples. In all, 50 or 20 μL blood samples were then collected via the standard or retrofitted unit, respectively, at six timepoints over a 7 h period. After drying and storage the DBS samples were analysed for propranolol via liquid chromatography-mass spectrometry. In this report we demonstrate that a standard DiLab(®) AccuSampler(®) can be easily retrofitted to facilitate automatic dried blood spot sampling and that time-concentration data generated from these samples are equivalent to that from manually spotted samples. |
| | |
Authors:
|
G T Clark; G Giddens; L Burrows; C Strand |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-2-25 |
Journal Detail:
|
Title: Laboratory animals Volume: - ISSN: 1758-1117 ISO Abbreviation: - Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-2-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0112725 Medline TA: Lab Anim Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide Research and Development, Sandwich, Kent CT13 9NJ, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclin...
Next Document: Shift work and chronic disease: the epidemiological evidence.